| FEATURES |
Newly Reduced Fees for
Trainees
From March 2022, in addition to
already offering the first
year of membership free to
trainees in nephrology, ISN membership
will now only cost $15 per year for
the following
four years while the member is in
training.
|
|
Join/renew now
and reap the many benefits of ISN
membership early in your career!
|
|
|
Deputy
Editor of Kidney
International Reports
Receives the NFK Excellence in
Transplantation Award
Please join us in congratulating
Sumit Mohan,
deputy editor of Kidney
International Reports,
on having received the National Kidney
Foundation (NFK) Excellence
in Transplantation Award, which
recognizes exceptional research
contributing novel insights to
improved access to kidney
transplantation.
|
|
|
Dr. Mohan is an associate professor of
medicine and epidemiology at Columbia
University. Among several significant
outcomes, his research findings have
positively impacted public policies for
patients with kidney disease and
improved access to kidney transplants.
|
|
|
2022
Renée Habib Award Goes to Rahul
Chanchlani
The ISN congratulates Rahul
Chanchlani on
receiving the Renée Habib award
from the International Pediatric
Nephrology Association.
|
|
The award recognizes young
investigators with an outstanding
record of achievement and
creativity in basic or
patient-oriented research related
to pediatric kidney care and
health.
|
|
|
Dr. Chanchlani is an associate
professor in the Division of
Nephrology, Department of Pediatrics at
McMaster Children’s Hospital, Ontario,
USA. He was a member of the inaugural
cohort, 2021-22, of the ISN Emerging
Leaders Program.
|
|
|
|
 |
Membership
|
|
Affiliated
Societies Meet to Share
Initiatives and Progress
In February, in conjunction with
WCN’22, the ISN held a meeting with
leaders of ISN Affiliated
Societies to discuss their
achievements over the past two
years and strengthen existing ties
between ISN and its Affiliated
Societies.
|
|
|
ISN President Agnes Fogo
and ISN Secretary-General and
Treasurer Fergus Caskey
moderated session one, which
covered North America and the
Caribbean, Latin America and
Western Europe, Africa, and Eastern
and Central Europe ISN regions.
Vivekanand Jha,
ISN Past President, and Masaomi
Nangaku, ISN
President-elect, moderated session
two, which covered the Middle East,
NIS and Russia, North and East
Asia, Oceania and Southeast Asia,
and South Asia ISN Regions.
|
|
All the societies in attendance
presented recent highlights from
their activities; from the launch
of a renal registry in the UK to
drafting manuals on the care and
treatment of hemodialysis patients
in Nepal, these regional
organizations continue to evolve to
best address the needs of their
local populations and beyond.
|
|
The event provided a timely
opportunity for societies from
different parts of the world to
strengthen connections and learn
from each other's initiatives.
Notably, the Mauritius Renal
Association and the South African
Renal Society agreed to
initiate a future collaboration.
|
|
|
|
|
|
|
|
LNDTA members will enjoy the full
benefits of ISN membership for a
tailored membership fee.
Collective-Member Society status
increases global activity and
visibility through ISN endorsement,
priority consideration for managing
joint events and complimentary
participation in the Global Village
at the World Congress
of Nephrology (WCN).
|
|
In addition, individual members of
these societies enjoy full
membership benefits, including ISN journals,
special event rates, and education
at the ISN Academy.
|
|
The ISN looks forward to working
closely with the LNDTA to advance
kidney health worldwide.
|
|
|
|
|
|
|
|
Grants
|
|
|
|
|
Interested but not ready to apply?
Prepare now for the next deadline,
October 1.
|
|
Consult the guidelines here.
|
|
|
Deadline
for Clinical Research Grants:
May 1 - Apply Now!
Read the application
guidelines and eligibility
criteria here.
|
|
If you are already an ISN member,
apply directly here.
|
|
Only applicants who have already
submitted a proposal to their
regional coordinator will be
considered for a clinical research
grant.
|
|
|
|
|
Give
Professional Guidance, Develop
Leadership Skills, Grow a
Global Network - Apply to
Become an ISN Mentor
Are you an ISN member or
associate member with
experience in clinical work,
research, career development, or
another area of expertise?
|
|
If so, benefit from an
international professional network
and develop coaching and leadership
skills as you connect with mentees
worldwide through the ISN Mentorship
Program, designed to foster
mutually beneficial
partnerships that encourage
expertise in advancing global
kidney care.
|
|
|
Applications for mentors are open
year-round. Apply to the
ISN Mentorship Program
via the online application platform
here.
|
|
All applications for mentors are
reviewed by the Mentorship
Advisory Group before they
are matched with a mentee.
|
|
Find out more about the Mentorship
Program here or
contact us at mentorship@theisn.org.
|
|
|
|
|
 |
Events
|
|
More Time
to Share Your Expertise at the
ISN Frontiers Meeting in New
Delhi - Submit Your Abstract
until May 4
The new deadline for abstract
submissions and travel grant
applications is May 4, 2022.
|
|
|
|
All accepted abstracts will be
published in Kidney
International Reports.
|
|
|
Take advantage of a valuable
opportunity to present your
research work on bi-directional
relationships between
infections and kidney diseases
to a diverse audience at the ISN Frontiers
Meeting in New Delhi.
|
|
The meeting will take place in
collaboration with the Indian Society
of Nephrology from September
22 to 25, 2022, in
New Delhi, India.
Discover the four-day
program here.
|
|
|
Register
for the Frontiers New Delhi
Webinar on Planetary Health,
Biodiversity and Sustainable
Healthcare
Join Vivekanand Jha,
Sunita Bavanandan
and Peter J. Blankestijn
at 2 p.m. CEST on Tuesday,
May 17.
|
|
|
|
|
As the COVID pandemic has shown,
environmental change is one of the
most significant risk factors for
future infections. The topic
“Planetary Health,
Biodiversity and Sustainable
Healthcare” is
greatly relevant to the kidney
health community given the
vulnerability of patients with
kidney diseases.
|
|
The webinar supports the ISN Frontiers
Meeting “Infections
and the Kidneys.”
|
|
|
|
|
 |
Advocacy
|
|
Promoting
Better Kidney Health
Post-Pandemic with the WHO’s
Intergovernmental Negotiating
Body
The ISN submitted a statement to
the World Health Organization’s
intergovernmental negotiating body
(INB) calling on member states to
prioritize ongoing prevention,
screening, and treatment for kidney
disease in national COVID-19
response and recovery plans in
support of global kidney health
during pandemics.
|
|
|
The ISN reiterates its invitation
to WHO Executive Board members and
other key countries to unite to
discuss how to help the INB
negotiate an international
instrument that will grant future
generations of kidney patients more
security in a pandemic scenario.
|
|
|
|
|
|
|
 |
YOUNG NEPHROLOGISTS
|
|
Young
Nephrologists: Apply Today to
Win a Free Pass to the 40th
Vincenza Course
The course will take place from
June 14 to 16, 2022,
at the Fiera di Vicenza Convention
Center in Vicenza, Italy.
|
|
The deadline to apply for a
free pass to the 40th
Vicenza Course on acute kidney
injury (AKI) and critical care in
nephrology is Tuesday,
April 26, 2022.
|
|
|
Applicants must be ISN members
under the age of 35 and submit an
abstract to the event on AKI or
critical care in nephrology. Learn
more about abstract submission here.
|
|
Download the application form
here.
|
|
|
|
|
|
|
 |
EDUCATION
|
|
Watch the
First Module of the Kidney
Stone Course and Register for
the Webinar on April 28
Watch “Why Kidney
Stones Form” here.
|
|
This first module of the Kidney
Stone Course is open access until
April 28.
|
|
Register for the webinar on
the metabolic evaluation of
patients with kidney stones here.
|
|
| Presentations from the webinar,
including Q&A sessions, will be
available to ISN
members on the
ISN Academy as course modules.
|
The kidney stone webinar and course
help:
-
recognize the burden that
kidney stones present to
patients
-
understand the causes of
kidney stone formation
-
understand preventative
treatments
|
|
|
|
|
Test Your
Knowledge of Onconephrology
ISNeducation
Social Media Team members
Divya Bajpai, Sibel Bek, Didem
Turgut, Suman Behara, Sourabh
Sharma, and Mohammad A. Gawad. have
developed a quiz on onconephrology:
|
|
|
|
|
The quiz was developed to accompany
the @ISNEducation Nuances in
Nephrology Webinar: Immune
Checkpoint Inhibitors
Nephrotoxicity in Native and Kidney
Transplantation available to ISN members
on the ISN Academy
here.
|
|
|
|
|
|
|
|
Tuesday,
April 26, 4 p.m. CEST
ISN-ISRNM
Webinar
Kidney Nutrition Care - Global
Perspective, Current State and
Strategies to Address Barriers
|
Speakers:
|
Angela
Yee-Moon Wang,
China
Ana Elizabeth
Figueiredo,
Brazil
Nazeema Easu,
South Africa
Vivekanand Jha,
India
Harun-Ur
Rashid,
Bangladesh
|
|
Moderator:
|
Aminu Bello,
Canada
|
|
|
|
Thursday,
April 28, 3 p.m. CEST
ISN
Webinar:
Metabolic
Evaluation of Patients with
Kidney Stones
|
Speakers:
|
David
S. Goldfarb,
USA
Giovanni
Gambaro, Italy
|
|
Moderators:
|
Andrej
Škoberne,
Slovenia
Roswitha
Siener, Germany
|
|
|
|
Friday,
May 6, 8 a.m. CEST
ISN-Cochrane
Webinar:
Oral Protein-based
Supplements Versus Placebo or
no Treatment for People with
Chronic Kidney Disease
Requiring Dialysis
|
Speakers:
|
Jia Yee Mah
(Vivian),
Australia
Melissa Corken,
Australia
Suet-Wan Choy,
Australia
|
|
Moderator:
|
Lawrence
McMahon,
Australia
|
|
|
|
Thursday,
May 12, 2 p.m. CEST
ISN
Webinar:
Developments in
Managing DKD - How Does it Look
in Practice?
|
Speakers:
|
Roberto
Pecoits-Filho,
USA
Csaba P
Kovesdy, USA
|
|
Moderator:
|
Angela
Yee-Moon Wang,
China
|
|
|
This webinar is
supported by an
unrestricted
educational grant
from 
|
|
|
|
Tuesday,
May 17, 2 p.m. CEST
ISN
Frontiers Webinar:
Planetary Health, Biodiversity
and Sustainable Healthcare
|
Speaker:
|
Peter
J Blankestijn,
The Netherlands
|
|
Moderators:
|
Vivekanand Jha,
India
Sunita
Bavanandan,
Malaysia
|
|
|
|
|
|
@ISNeducation Nuances
in Nephrology Webinar:
Immune Checkpoint
Inhibitors
Nephrotoxicity in
Native and Kidney
Transplantation
|
|
|
|
|
|
 |
COVID-19
|
|
Kidney
International on
COVID-19
|
|
|
Kidney
International Reports
on COVID-19
|
|
|
|
|
 |
Journals
|
|
Watch the
Latest ISN Video Abstract on a
First-in-human Phase 1 Study of
Nedosiran (PHYOX1) in Primary
Hyperoxaluria
Watch the latest video abstract here.
|
|
|
|
|
|
|
|
Kidney International Editorial
Selection
|
|
Clinical
Outcomes from the Assessing
Donor-derived Cell-free DNA
Monitoring Insights of Kidney
Allografts with Longitudinal
Surveillance (ADMIRAL) Study
Routine monitoring of donor-derived
cell-free DNA (dd-cfDNA) after
kidney transplant may allow
clinicians to identify subclinical
allograft injury and intervene
before the development of
clinically evident graft injury.
|
|
| In this study, data from 1092
kidney transplant recipients
monitored for dd-cfDNA over three
years was analyzed to assess the
association of dd-cfDNA with
histologic evidence of allograft
rejection.
|
|
Persistently elevated dd-cfDNA
predicted over a 25% decline in the
estimated glomerular filtration
rate over three years, indicating
that routine monitoring of dd-cfDNA
does permit early identification of
clinically important graft injury.
|
|
|
|
|
|
|
|
Kidney International
Reports Editorial
Selection
|
|
Management of
Hypertension in
Patients with
Diabetic Kidney
Disease:
Summary of the
Joint
Association of
British
Clinical
Diabetologists
and UK Kidney
Association
Guideline 2021
|
|
|
Diabetic kidney disease
(DKD) accounts for over
40% of chronic kidney
disease (CKD) cases
globally. Because
hypertension is a major
risk factor for the
progression of DKD and
the high incidence of
cardiovascular disease
and mortality in these
people, careful
management of
hypertension is
essential to slow the
progression of DKD and
reduce cardiovascular
risk.
|
|
Jointly developed by
diabetologists and
nephrologists, the
guideline has reviewed
all available current
evidence on managing
hypertension in DKD to
generate a
comprehensive set of
individualized
recommendations for
blood pressure control
and the use of
antihypertensive agents
according to age, type
of diabetes, and stage
of CKD.
|
|
|
|
|
|
|
|
